Faculty Associates

Michael D. Murray

Contact Information
Email: mmurray |at| regenstrief.org
Phone: (317) 630-6482
Fax: (317) 630-8776
Distinguished Professor of Pharmacy Practice
Executive Director of the Regenstrief Center for Health Effectiveness Research

PubMed Listing
Google Scholar Listing

PDF icon View Vita

Education


PharmD Duquesne University 1977
Master of Public Health Indiana University 1992

Research Interests


Improving medication use and safety in people with chronic diseases, factors affecting patient adherence to their chronic medications, pharmacoepidemiology of chronically administered medications, pharmacy services research in ambulatory settings, health care utilization of low-income minority people with chronic diseases

Grants


National Institute on Aging
National Heart, Lung, and Blood Institute
GlaxoSmithKline
Regenstrief Foundation

Publications


Overhage JM, Gandhi TK, Hope C, Seger A, Murray MD, Orav J, Bates DW. (in press). Ambulartory Computerized Prescribing and Adverse Drug Events. Journal of Patient Safety.

Chin J, Payne B, Gao X, Conner-Garcia T, Graumlich JF, Murray MD, Morrow DG, Stine-Morrow EA. (2014). Memory and comprehension for health information among older adults: Distinguishing the effects of domain-general and domain-specific knowledge. Memory, 30:1-13.

Murray MD. (2013). Pharmacoepidemiology and pharmacovigilance. In The Science and Practice of Pharmacy, (22nd edition, pp. 2467-2475), edited by Allen LV, Jr. Pharmaceutical Press.

Aljadhey H, Adam M, Mayet A, Alshaikh M, Kalagi N, Altaweel L, Ahmed Y, Murray MD, Bates DW. (2013). Incidence of adverse drug events in an academic hospital: A prospective cohort study. International Journal for Quality in Health Care. 25(), 648-655.

Aljadhey H, Alhusan A, Alburikan K, Adam M, Murray MD, Bates DW. (2013). Medication safety practices in hospitals: A national survey in Saudi Arabia. Saudi Pharm J. 21(2), 159-164.

Inui TS, Plater D, Blatchley III E, Einertz R, Murray MD, Shekhar A, Taylor K, Tierney W. (2013). More than a walk in the park: The Indiana Global Health Research Meeting. 28(s3), 615-620.

Aljadhey, H., Alyabsi, M., Alrwisan, A., Alqahtani, N., Almutari, R., Altaweel, I., Adam, H., Shakir, S. Aljeraisy, M., Al-Blowi, A., Alkashan, H., Albogami, Y., & Murray, M. D. (2012). The safety of H1N1 vaccine in children in Saudi Arabia: A cohort study using modern technology in developing country. Drug Safety, 35, 555-561.

Campbell, N., L., Boustani, M. A., Skopeljia, E. N., Gao, S., Unverzagt, F. W., & Murray, M. D. (2012). Medication adherence in older adults with cognitive impairment: A systematic evidence-based review. The American Journal of Geriatric Pharmacotherapy, 10, 165-177.

Kim, K., Murray, M. D., Tu., W., Robarge, J., Ding, Y., Brater, D., & Flockhart, D. (2012). Pharmacogenetics and healthcare outcomes in patients with chronic heart failure. European Journal of Clinical Pharmacology, 68, 1483-1491.

Morrow, D., D'Andrea, L., Stine-Morrow, E. A. L., Shake, M., Bertel, S., Chin, J., Kopren, K., Gao, X., Conner-Garcia, T., Graumlich, J., & Murray, M. D. (2012). Comprehension of multimedia health information among older adults with chronic illness. Visual Communications, 11, 47-362.

Noureldin, M., Plake, K., Morrow, D., Tu, W., Wu, J., & Murray, M. D., (2012). Efffect of health literacy on medication adherence in patients with heart failure. Pharmacotherapy, 32(9), 819-826.

Yamani, Y., Chin, J., Meyers, E., Gao, X., Morrow, D., Stine-Morrow, E., Conner-Garcia, T., Graumlich, J., & Murray, M. D. (2012). Reading engagement offsets declines in processing capacity for health literacy. Human Factors and Ergonomics Society, 56(1), 916-920.

Murray MD. (2011). Curricular considerations for pharmaceutical comparative effectiveness research. Pharmacoepidemiology Drug Safety. 20(8):797-804

Murray MD and Harrison J. (2010). Prescription abandonment: another path to medication nonadherence. Ann Intern Med (10): 680-681.

Aljadhey H, Tu W, Hansen RA, Blalock S, Brater C, and Murray MD. (2010). Risk of hyperkalemia associated with selective COX-2 inhibitors. Pharmacoepidemiology and Drug Safety 19: 194-98.

Murray MD. (2010). Implementing pharmacy practice programs for the management of heart failure. Pharm World Sci 32(5): 546-548.

Roth AM, Ackermann RT, Downs SM, Downs AM, Zillich AJ, Holmes AM, Katz BP, Murray MD, and Inui TS. (2010). The Structure and Content of Telephonic Scripts Used Effectively in the Indiana Medicaid Chronic Disease Management Program. Chronic Illness 6: 83-88.

Gandhi TK, Seger AC, Overhage JM, Murray MD, Hope C, Fiskio J, Teal E, and Bates DW. (2010). Outpatient adverse drug events identified using electronic health record screening. J Patient Safety 6(2): 91-96.

Report a Problem